The reason this randomised controlled trial is important is because it addresses a common challenge for primary healthcare services internationally. The intervention aims to promote appropriate parental demand for consultations and antibiotics for children with respiratory tract infections (RTIs). This is important for parents, clinicians and policy for three reasons. First, RTIs are extremely common and are costly to service providers, families, schools and parents’ employers.1 Second, there is considerable clinical uncertainty in primary care regarding the diagnosis and best management of RTIs. This is reflected by the variation in the use of antibiotics …